XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant

Source
Translational oncology - ISSN 1936-5233-43 (2024) p. 1-13
Author(s)

The evolution and prognostic role of tumour-infiltrating lymphocytes and peripheral blood-based biomarkers in inflammatory breast cancer patients treated with neoadjuvant chemotherapy

Source
Cancers - ISSN 2072-6694-13:18 (2021) p.
Author(s)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Source
Oncoimmunology - ISSN 2162-402X-10:1 (2021) p.
Author(s)